Type 2 diabetes clinical trials
1,684 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all type 2 diabetes studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting type 2 diabetes studies. A study counts once in each state where it has a site.
- California180
- Texas145
- Florida125
- New York104
- Pennsylvania100
- Ohio95
- North Carolina91
- Illinois88
- Maryland84
- Georgia82
- Massachusetts80
- Tennessee73
Also in China (201), Canada (142), France (124), United Kingdom (102), Italy (95), Spain (95), Germany (94), Denmark (75).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 130
- Phase 160
- Phase 1 / Phase 236
- Phase 2103
- Phase 2 / Phase 314
- Phase 3119
- Phase 4113
- No phase (devices, programs)778
- Observational431
Recently updated studies
Recruiting type 2 diabetes studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingNo phase (devices, programs)NCT07398300
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
Ages 23 Years – 64 Years · Copenhagen, Denmark · Copenhagen University Hospital, Rigshospitalet
- RecruitingObservationalNCT07285330
Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
Ages 18 Years and over · Vilafranca del Penedès, Barcelona · Consorci Sanitari de l'Alt Penedès i Garraf
- RecruitingObservationalNCT05054361
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Ages 12 Months – 15 Years · Antony, France · Paris, France · Institut National de la Santé Et de la Recherche Médicale, France
- RecruitingPhase 2NCT07808151
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Ages 18 Years and over · Los Angeles, California · Tampa, Florida +26 more · Solstice Oncology, Inc.
- RecruitingPhase 3NCT03486873
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Ages 18 Years and over · Tucson, Arizona · Bakersfield, California +544 more · Merck Sharp & Dohme LLC
- RecruitingObservationalNCT06668935
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
Ages 18 Years and over · Paradise Valley, Arizona · Jacksonville, Florida +6 more · Abbott Diabetes Care
- RecruitingPhase 2NCT07271186
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ages 18 Years – 80 Years · Huntsville, Alabama · Little Rock, Arkansas +49 more · Regeneron Pharmaceuticals
- RecruitingObservationalNCT07584330
AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults
Ages 18 Years – 60 Years · Guangzhou, Guangdong · Zhujiang Hospital
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.